Product review · Updated September 30, 2026
Cetaphil Gentle Clear Pore Clearing review: the gel, the tiles and the older cream
The matching gel declaration is more precise than generic ingredient panels or a separate historical cream label.
Editorial source review, with no clinician sign-off or firsthand treatment experience claimed.
Cetaphil’s Gentle Clear Pore Clearing Acne Cleanser combines a 2% salicylic declaration with foaming-gel and dryness-relief wording. Its product page also contains broader ingredient explanations that do not all appear in this cleanser’s own panel. Reading the entire page as one formula would therefore make the cleanser seem to contain ingredients its complete declaration does not name.
We reviewed the US-facing gel and its May 9, 2024, Galderma label on September 30, 2026. We also read a November 20, 2023, Clarifying Acne Cream Cleanser label because the older cream name matters to product identification. The records distinguish names, package sizes and bases; they do not prove a rebranding history, discontinuation or the formula inside an unseen purchased bottle.
In this article
Pore Clearing is the foaming gel in this record
The selected manufacturer page calls this a foaming gel cleanser with 2% salicylic acid and shows an 8 oz size. The matching posted label names Gentle Clear Pore Clearing Acne Cleanser and identifies Galderma as packager. This review concerns that exact item, rather than a neighboring benzoyl-peroxide product or the older cream. Current gel; dated label.
The May 9, 2024, label carries NDC 0299-4143-00 and an 8 fl oz, 237 mL principal panel. Those are useful identifiers for the record being compared. They do not establish actual retail stock or guarantee that every package someone encounters has this declaration. A product name and size help define scope before any comfort claim is evaluated.
The complete panel supplies the actual gel formula
The manufacturer separates 2% salicylic acid as active from a full inactive panel. That panel agrees with the posted label’s prose declaration, including glycerin, shea butter, soybean oils, lactic acid and benzyl alcohol. These are named constituents of the identified gel record, not a claim that any single ingredient determines how the product feels. Website panel; label panel.
The agreement is stronger formula documentation than a generic ingredient tile. It remains a qualitative declaration rather than an assay of an individual batch. The combination-formula guide provides additional context for considering the complete base without assuming that the headline acne ingredient or a moisturizing component supplies the entire product story.
Clarifying Acne Cream is a distinct older label
The November 20, 2023, Galderma record names Clarifying Acne Cream Cleanser. Its principal panel describes a 124 mL tube, under the separate NDC 0299-4119 family. Its inactive list includes cetyl and stearyl alcohols, aloe and tea extract. This is not the same declaration as the chosen 237 mL Pore Clearing gel. Historical cream label; gel declaration.
The dates and differences establish two documented records, not why they differ or whether one replaced the other everywhere. We do not call the cream discontinued or transfer its base to the gel. The Mario Badescu review is another cleanser reading option, with no implied equivalence of formula, package history or clinical performance.
Generic ingredient explanations do not expand this panel
The gel page contains a triple-acid tile describing salicylic acid, mandelic acid and gluconolactone, plus separate niacinamide and panthenol explanations. Mandelic acid, gluconolactone, niacinamide and panthenol are absent from this product’s complete inactive panel. We therefore do not add them to the cleanser simply because those tiles appear nearby. Tiles and product panel.
The appropriate boundary is between a general site ingredient explanation and the declaration attached to a named item. It is not proof that the tile ingredients have no role elsewhere in the range. The exact gel list and matching posted label provide a more precise basis for the review than a page-wide collection of potentially appealing ingredient descriptions.
Twenty-four-hour dryness relief remains a product claim
Cetaphil attributes 24-hour dryness relief to an Advanced Moisture Blend and describes the gel as clinically tested on sensitive skin. The posted principal panel repeats the dryness-relief wording. The returned records do not supply a complete study report, denominator or comparison protocol that would let this review independently assess the magnitude of that claim. Manufacturer account; package wording.
A stated test and a full formula are different kinds of documentation. One does not repair missing details in the other. The Clearasil review offers another exact wash record for further reading, without suggesting that the manufacturers’ different marketing periods measure an equivalent outcome or establish which cleanser is more comfortable.
The gel’s warnings coexist with the comfort wording
The selected gel label warns about increased dryness or irritation with another topical acne medication and contains a severe-irritation warning. Those fields remain meaningful beside a sensitive-skin description and dryness-relief headline. This review reports their presence without constructing a combination schedule or deciding whether an individual should use the product. Gel warnings.
AAD’s general moisture guidance also identifies salicylic acid as potentially drying or irritating, but it does not test Cetaphil’s particular blend. The mature dry-skin guide offers broader context for the comfort question. Neither source turns a favorable description into an assurance that a new symptom is harmless or supplies personal clinical clearance. AAD explanation.
The matching declaration is the fair comparison unit
For this cleanser, the strongest documentation is the agreement between the current gel’s full manufacturer panel and its specifically identified posted label. The historical cream and generic tiles explain why a broader reading could be misleading. Actual batch contents, full comfort methods and an individual outcome remain outside what these records establish. Gel panel; matching label.
The product comparison offers further reading about separating format and evidence. A responsible Cetaphil summary keeps the gel’s identity, whole base and comfort claims together while preserving their limits. It does not assemble a richer formula from unrelated tiles, borrow the older cream’s ingredients or turn a familiar brand into a clinical winner.
Sources behind this reading
- Cetaphil Gentle Clear Pore Clearing Acne Cleanser: exact US gel ↗Official manufacturer public product/brand record; source-specific scope · Checked September 30, 2026
- DailyMed: Galderma Cetaphil Pore Clearing Acne Cleanser, May 9, 2024 label ↗Official packager labeling record; dated and package-version limits · Checked September 30, 2026
- DailyMed: Galderma Cetaphil Gentle Clear Clarifying Acne Cream Cleanser, November 20, 2023 label ↗Official posted US OTC product label; historical distinct cream/version record · Checked September 30, 2026
- American Academy of Dermatology: moisturizer and acne treatment ↗Medical society patient guidance · Checked September 30, 2026